About Contact Us Careers

Migraine Nasal Spray Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 4059
Published Date: Sep 16, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Solar Cell Landscape

Upsher-Smith Laboratories, LLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Dr. Reddy’s Laboratories Ltd.
AstraZeneca PLC
GlaxoSmithKline plc
Leucadia Pharmaceuticals (Custopharm, Inc.)
Assertio Therapeutics, Inc
Cipla Inc.
Impel Neuro Pharma.Inc
Tonix Pharmaceuticals Holding Corp.
Amneal Pharmaceuticals LLC

Browse Key Market Insights with Data Illustration:

Migraine Nasal Spray Market Size & Share, Growth Report 2036

In the News

March 22, 2022: Impel NeuroPharma, the manufacturer of migraine nasal spray Trudhesa, presented drug performance data at the 2022 scientific meeting of the American Academy of Neurology. The latest data shows rapid and consistent migraine relief with Trudhesa treatment.

Author Credits: Radhika Pawar

Report ID: 4059
Published Date: Sep 16, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The exponentially increasing number of migraine patients worldwide is the leading cause of the widening demand for migraine nasal sprays.

The market is anticipated to attain a notable CAGR over the forecast period, i.e., 2022-2031.

People often experience side effects such as unusual taste in the mouth, dizziness, and dry eyes. These adverse effects are estimated to hamper the market growth.

North America region is estimated to provide a good business opportunity for the market on account of good healthcare infrastructure and rising awareness among people.

The major players in the market are Upsher-Smith Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Cipla Inc, Dr. Reddyâ€™s Laboratories Ltd, Assertio Therapeutics, Inc., and Impel Neuro Pharma. Inc.

Inquiry Before Buying Request Free Sample